Europe is currently benefiting from a dynamic MedTech start-up ecosystem. However, not so many of these start-ups succeed in scaling-up. What are the possible strategies and paths to get bigger on MedTech market in Europe? What do we lack in order to accompany the scaling-up of MedTech companies? How to grow the private equity and stock markets to enable more frequent success in that process? How to ensure that the development and consolidation of the sector are also fuelled by MedTech SMEs merger and acquisition deals?
How to increase the number of MedTech unicorns in Europe?
Moderated roundtable discussion consisting in an exchange of ideas and perspectives by international experts to delve into the latest challenges of the sector.
- 11:00 AM
- 12:30 PM
- Tina Tan, Executive Editor, MedTech, FIRSTWORD
- Nicolas Durand, CEO and founder, ABIONIC
- Martin Frost, CEO and Co-Founder, CMR SURGICAL
- Gérard Hascoët, Executive Chairman, MD START
